Please assess the completion status of the following clinical trial:

Trial Title: Investigating the Role of Impella 2.5 System in Acutely Decompensated Chronic Heart Failure Patients

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Major Inclusion Criteria:~1. Chronic heart failure patients, hospitalized due to decompensated heart failure (ADHF) with NYHA Class III-IV symptoms (ADHF is defined by the presence of at least one of the following symptoms/signs: dyspnea w/orthopnea, jugular venous distension, peripheral edema +2, abdominal ascites, signs of CHF on chest X-Ray)~2. LVEF ≤ 40 % within the past 3 months~Major Exclusion Criteria:~1. Acute Q-wave myocardial infarction or Acute coronary syndrome within past 30 days~2. Cardiac surgery within the past 30 days~3. Implantation of cardiac resynchronization device within past 30 days or a possibility of implanting a biventricular pacer within 90 days of randomization

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).